EFFECT OF DAPAGLIFLOZIN, SITAGLIPTIN AND METFORMIN COMBINATION ON SOME METABLIC RISK FACTORS IN IRAQI PATIENTS WITH TYPE-2 DIABETES MELLITUS. NPPH [Internet]. 2024 Jan. 22 [cited 2025 Jan. 19];22(1):204-9. Available from: http://neuropsychopharmacologiahungarica.com/index.php/NPPH/article/view/17